Cervical cancer has emerged as the fastest-growing cancer in Canada, signalling a pressing health emergency that requires immediate government intervention. This stark warning was issued during a recent press conference held by the Society of Gynecologic Oncology of Canada in Ottawa. Despite the federal government outlining a plan in July 2025 to eradicate cervical cancer as a public health issue by 2040, experts argue that current measures are insufficient to address this escalating crisis.
An Alarming Trend
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, highlighted the troubling statistics surrounding this disease. In 2025, an estimated 1,650 Canadians were diagnosed with cervical cancer, leading to 430 fatalities—deaths that are deemed preventable. “Canada is currently grappling with a silent national health crisis,” Salvador remarked, underscoring the disparity between medical advancements and actual outcomes for patients.
The reliance on traditional Pap tests and a stagnating uptake of the human papillomavirus (HPV) vaccination has contributed to this disconcerting trend. Currently, only 64 per cent of the eligible population has completed the HPV vaccination series, a figure far below the levels necessary for effective elimination of the disease. “This statistic reflects not just a medical failure, but a comprehensive policy failure,” Salvador stated, calling for a reassessment of the current approach.
A Shift in Screening Strategies
In light of these challenges, the Society of Gynecologic Oncology of Canada is advocating for a transformative shift towards HPV DNA testing for cervical cancer screening. They propose the adoption of self-collection kits, which would allow individuals to conduct testing in the privacy of their homes. This approach aims to dismantle barriers to access, particularly for those living in rural or underserved communities.
Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, noted that Indigenous women are disproportionately affected by cervical cancer, facing higher diagnosis rates and poorer outcomes. “This is not due to biological differences, but rather a result of systemic barriers, including geographic isolation and racism within the healthcare system,” Kean explained. The introduction of self-collection kits could mitigate these issues, making screening more accessible to those who might otherwise fall through the cracks.
The Economic Implications
The economic burden of cervical cancer is considerable, with the costs to the Canadian healthcare system projected to reach $132 million in 2024. In comparison, implementing a comprehensive screening strategy would require an investment of approximately $106 million over five years. These figures highlight the urgent need for a strategic overhaul of both screening and vaccination efforts to prevent further loss of life and alleviate the financial strain on the healthcare system.
Despite the World Health Organization’s global strategy launched five years ago to eliminate cervical cancer, a report from the Canadian Cancer Society released in November 2025 indicates that progress has stalled. The report reveals that cervical cancer remains the fourth most diagnosed cancer and a leading cause of cancer-related deaths among women globally. In Canada, the five-year survival rate stands at 74 per cent, but the decline in incidence rates has slowed alarmingly, particularly since 2005.
Why it Matters
The rising incidence of cervical cancer in Canada is not merely a statistic; it is a reflection of systemic failures in public health policy and access to care. As the country strives to meet its goal of eliminating this preventable disease by 2040, the urgency for a comprehensive and inclusive approach has never been clearer. By investing in innovative screening methods and ensuring equitable access to vaccinations, Canada can not only save lives but also set a precedent for addressing other health disparities within its borders. The time for action is now; the health of future generations depends on it.
